Citizen Portal
Sign In

Sunnyside Unified trust posts $295,000 net loss for fiscal year; trustees review investments and August cash balance

5838180 · September 22, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Financial staff presented a full‑year statement showing contributions down slightly, claims up and a net loss; trust assets include multimillion-dollar investments and a cash balance of about $1 million at the end of August.

On Sept. 24 Sunnyside Unified District Trust received its fiscal reports covering the full year July 1–June 30 and an August interim report showing the trust ended the fiscal year with higher claims and an operating loss but maintained multimillion‑dollar investments.

Stephanie (financial staff) presented the full‑year income statement. She said contributions for the 2025 fiscal year were about $7.7 million compared with roughly $8.0 million the prior year, and that total revenue for the year was about $9.8 million. Total expenses were about $10.2 million, producing a net trust loss of roughly $295,000 for the year. Medical claims for the year were approximately $5.3 million and prescription claims were approximately $2.2 million, increases that staff cited as the primary drivers of the expense growth.

Stephanie said the trust’s balance sheet at June 30 included cash, receivables and investments. She reported investments in the district’s portfolios and money market holdings; the board was shown investment totals and an unencumbered net asset position that staff described as several months’ worth of contributions. For the two‑month August interim, Stephanie reported roughly $939,000 in revenue and total expenses of about $1.4 million, a net loss consistent with normal seasonal cash timing for the trust. She said the cash balance at the end of August was about $1 million and that investments had increased modestly in the two months following the fiscal year end.

Why it matters: the trust’s reserves, investment income and claims experience determine the fund’s ability to smooth premiums and pay benefits without exceptional assessment changes.

Board members asked whether prescription claims could be broken down by major drivers or by PBM reports. District staff said Prime Therapeutics is the PBM and will be asked to supply detailed reports for specific high‑cost drug categories. Staff also noted some fees — such as Pearmatrix Rx savings fees — increased alongside program activity.

No formal fiscal actions (rate changes, transfers or new investment directives) were voted at the meeting; the reports were received and staff were directed to provide additional PBM detail on request.